Elan makes new board appointment

ELAN has announced the appointment of William Rohn to the company’s board of directors.

Mr Rohn has extensive experience in the biotech and pharmaceutical industry. He is currently vice-chairman of Raven Biotechnologies and a director of Metabasis Therapeutics, Cerus and Pharmacyclics.

He was formerly chief operating officer of Biogen Idec.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited